Implementing an electronic end-of-life chemotherapy utilization measure Published March 2020 Citation Kraut J, Mooney K, Sweetenham JW, Page RD, Adelson K, Agarwala V, Fessele KL, Hamrick HJ, Kaganman I, Martineau J, Abernethy AP, and Meropol NJ. . Journal of Oncology Practice. . http://ascopubs.org/doi/abs/10.1200/JOP.18.00408 Authors:Kraut J, Mooney K, Sweetenham JW, Page RD, Adelson K, Agarwala V, Fessele KL, Hamrick HJ, Kaganman I, Martineau J, Abernethy AP, and Meropol NJ Sources:Journal of Oncology Practice Share Posted inPublicationsTreatment patterns More publicationsASH Annual MeetingNovember 2025Real-world treatment patterns and survival outcomes in second and third line settings in large B-cell lymphomaMcGuirk J, Perales M, Fesen M, et al.Publication summaryPublicationsTreatment patternsDiffuse large B-Cell lymphomaASH Annual MeetingNovember 2025Use and outcomes following blinatumomab rechallenge in adolescents and young adults and adults with B-cell acute lymphoblastic leukemiaUse and outcomes following blinatumomab rechallenge in adolescents and young adults and adults with B-cell acute lymphoblastic leukemia (B-ALL)Publication summaryPublicationsTreatment patternsASH Annual MeetingNovember 2025Real-world treatment patterns and clinical outcomes in high-risk mantle cell lymphoma: A retrospective analysisJain P, Teschemaker A, Ibrahim E, et al.Publication summaryPublicationsTreatment patterns